Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
T. Joseph Raoof, MD, Inc.
1179
mi
from
Encino, CA
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
T. Joseph Raoof, MD, Inc.
1179
mi
from
Encino, CA
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
University Clinical Trials, Inc.
1143
mi
from
San Diego, CA
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
University Clinical Trials, Inc.
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Tory Sullivan MD PA
1315
mi
from
North Miami Beach, FL
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Tory Sullivan MD PA
1315
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
International Clinical Research - US, LLC
1134
mi
from
Sanford, FL
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
International Clinical Research - US, LLC
1134
mi
from
Sanford, FL
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Moore Clinical Research, Inc.
1115
mi
from
Tampa, FL
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Moore Clinical Research, Inc.
1115
mi
from
Tampa, FL
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Visions Clinical Research
1279
mi
from
Wellington, FL
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Visions Clinical Research
1279
mi
from
Wellington, FL
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
DermResearch, PLLC
658
mi
from
Louisville, KY
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
DermResearch, PLLC
658
mi
from
Louisville, KY
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Lawrence J. Green, MD, LLC
1120
mi
from
Rockville, MD
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Lawrence J. Green, MD, LLC
1120
mi
from
Rockville, MD
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Minnesota Clinical Study Center
559
mi
from
Fridley, MN
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Minnesota Clinical Study Center
559
mi
from
Fridley, MN
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Las Vegas Dermatology
970
mi
from
Las Vegas, NV
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Las Vegas Dermatology
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Academic Dermatology Associates
522
mi
from
Albuquerque, NM
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Academic Dermatology Associates
522
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Skin Search of Rochester, Inc
1120
mi
from
Rochester, NY
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Skin Search of Rochester, Inc
1120
mi
from
Rochester, NY
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dermatology Consulting Services
990
mi
from
High Point, NC
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dermatology Consulting Services
990
mi
from
High Point, NC
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
The Skin Wellness Center, PC
767
mi
from
Knoxville, TN
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
The Skin Wellness Center, PC
767
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
International Clinical Research - Tennessee LLC
645
mi
from
Murfreesboro, TN
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
International Clinical Research - Tennessee LLC
645
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
DermResearch, Inc.
507
mi
from
Austin, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
DermResearch, Inc.
507
mi
from
Austin, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
J&S Studies
503
mi
from
College Station, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
J&S Studies
503
mi
from
College Station, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Studies, LTD, LLP
572
mi
from
Houston, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Studies, LTD, LLP
572
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Suzanne Bruce and associates P.A. The Center for skin Research
569
mi
from
Houston, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Suzanne Bruce and associates P.A. The Center for skin Research
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Suzanne Bruce and Associates The Center for Skin Research
562
mi
from
Katy, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Suzanne Bruce and Associates The Center for Skin Research
562
mi
from
Katy, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Austin Institute for Clinical Research, Inc.
505
mi
from
Pflugerville, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Austin Institute for Clinical Research, Inc.
505
mi
from
Pflugerville, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Progressive Clinical Research
570
mi
from
San Antonio, TX
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Progressive Clinical Research
570
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dermatology Research Center
775
mi
from
Salt Lake City, UT
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dermatology Research Center
775
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
The Education and Research Foundation, Inc.
1019
mi
from
Lynchburg, VA
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
The Education and Research Foundation, Inc.
1019
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Premier Clinical Research
1202
mi
from
Spokane, WA
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Premier Clinical Research
1202
mi
from
Spokane, WA
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Kirk Barber Research
1214
mi
from
Calgary,
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Kirk Barber Research
1214
mi
from
Calgary,
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Michigan Center for Skin Care Research
852
mi
from
Clinton Township, MI
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Michigan Center for Skin Care Research
852
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
841
mi
from
Detroit, MI
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
Safety and Preliminary Efficacy of Combination Blue Light Phototherapy and Microcurrent Therapy for the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
NSU COM Division of Dermatology, General, Cosmetic Dermatology and Cutaneous Surgery
1303
mi
from
Fort Lauderdale, FL
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
Safety and Preliminary Efficacy of Combination Blue Light Phototherapy and Microcurrent Therapy for the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
NSU COM Division of Dermatology, General, Cosmetic Dermatology and Cutaneous Surgery
1303
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
Safety and Preliminary Efficacy of Combination Blue Light Phototherapy and Microcurrent Therapy for the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Hollywood Dermatology
1310
mi
from
Hollywood, FL
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
Safety and Preliminary Efficacy of Combination Blue Light Phototherapy and Microcurrent Therapy for the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Hollywood Dermatology
1310
mi
from
Hollywood, FL
Click here to add this to my saved trials
Gene Expression Following Ultherapy® Treatment
Evaluation of Changes in Gene Expression Following Ultherapy® Treatment
Status: Enrolling
Updated:  12/31/1969
North Valley Plastic Surgery
852
mi
from
Phoenix, AZ
Gene Expression Following Ultherapy® Treatment
Evaluation of Changes in Gene Expression Following Ultherapy® Treatment
Status: Enrolling
Updated: 12/31/1969
North Valley Plastic Surgery
852
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gene Expression Following Ultherapy® Treatment
Evaluation of Changes in Gene Expression Following Ultherapy® Treatment
Status: Enrolling
Updated:  12/31/1969
Campbell Facial Plastic Surgery
640
mi
from
Mequon, WI
Gene Expression Following Ultherapy® Treatment
Evaluation of Changes in Gene Expression Following Ultherapy® Treatment
Status: Enrolling
Updated: 12/31/1969
Campbell Facial Plastic Surgery
640
mi
from
Mequon, WI
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
TriWest Research Associates, LLC
1130
mi
from
El Cajon, CA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
TriWest Research Associates, LLC
1130
mi
from
El Cajon, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Univ of Calif., Los Angeles; Rheumatology
1179
mi
from
Los Angeles, CA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Univ of Calif., Los Angeles; Rheumatology
1179
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Arthritis Associates of Southern California
1178
mi
from
Los Angeles, CA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates of Southern California
1178
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Georgetown Uni. Hosp.; Rheumatology, Immunology and Allergy Dept.
1124
mi
from
Washington,
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Georgetown Uni. Hosp.; Rheumatology, Immunology and Allergy Dept.
1124
mi
from
Washington,
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Rheumatology Assoc. of S. Florida - Clinical Research Center
1298
mi
from
Boca Raton, FL
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Rheumatology Assoc. of S. Florida - Clinical Research Center
1298
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Millenium Research
1126
mi
from
Ormond Beach, FL
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Millenium Research
1126
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Arthritis Center Palm Harbor
1098
mi
from
Palm Harbor, FL
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Arthritis Center Palm Harbor
1098
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Boston Univ Med Center - AC
1443
mi
from
Boston, MA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Boston Univ Med Center - AC
1443
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
West Michigan Rheumatology
739
mi
from
Grand Rapids, MI
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
West Michigan Rheumatology
739
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Steffens Scleroderma Center
1309
mi
from
Albany, NY
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Steffens Scleroderma Center
1309
mi
from
Albany, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Joint and Muscle Research Institute
958
mi
from
Charlotte, NC
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Joint and Muscle Research Institute
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Arthritis & Rheumatology Center Of Oklahoma Pllc
157
mi
from
Oklahoma City, OK
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Arthritis & Rheumatology Center Of Oklahoma Pllc
157
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Oklahoma Center for Arthritis Therapy & Research, Inc.
151
mi
from
Tulsa, OK
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Oklahoma Center for Arthritis Therapy & Research, Inc.
151
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson Uni ; Division of Rheumatology
1225
mi
from
Philadelphia, PA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson Uni ; Division of Rheumatology
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of Reading, LLC
1183
mi
from
Wyomissing, PA
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Reading, LLC
1183
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
West Tennessee Research Institute
520
mi
from
Jackson, TN
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
West Tennessee Research Institute
520
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated:  12/31/1969
Metroplex Clinical Research
348
mi
from
Dallas, TX
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis
Status: Enrolling
Updated: 12/31/1969
Metroplex Clinical Research
348
mi
from
Dallas, TX
Click here to add this to my saved trials